Bibliography
- Centre for Medicines Research International. International Pharmaceutical R&D Factbook. Thomson Reuters (2009).
- Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other purposes. Off. J. Eur. Comm. L358, 1–29 (1986).
- Commission of the European Communities, Brussels, 5.11.2007. COM(2007) 675 final. Fifth Report on the Statistics on the Number of Animals used for Experimental and other Scientific Purposes in the Member States of the European Union {SEC(2007)1455}.
- Combes RD , BerridgeT, ConnellyJet al. Early microdose studies in human volunteers can minimise animal testing: proceedings of a workshop organised by volunteers in research and testing. Eur. J. Pharmacol. Sci. 19, 1–11 (2003).
- Boston Consulting Group. A revolution in R&D – how genomics and genetics will affect drug development costs and times. In: Parexel Pharmaceutical R&D Statistical Sourcebook. (2002/2003).
- Animal Procedures Committee. The use of primates under the Animals (Scientific Procedures) Act (1986): analysis of current trends with particular reference to regulatory toxicology. (2002).
- Home Office. Statistics of Scientific Procedures on Living Animals Great Britain 2008. HC 800. The Stationery Office, London, UK (2009).
- Focus on Alternatives. Submission to the Expert Working Group studying the TGN1412 incident. Appendix to Bhogal N and Combes R. An update on TGN1412. ATLA34, 351–356 (2006).
- Deeken JF , FiggWD, BatesSE, SparreboomA. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics. Anticancer Drugs18, 111–126 (2007).
- Sparreboom A . Unexplored pharmacokinetic opportunities with microdosing in oncology. Clin. Cancer Res. 13, 4033–4034 (2007).
- Coecke S , BlaauboerBJ, ElautGet al. Toxicokinetics and metabolism. In: Alternative (Nonanimal) Methods for Cosmetics Testing: Current Status and Future Prospects. A Report Prepared in the Context of the 7th Amendment of the Cosmetics Directive. ATLA. 33(Suppl. 1), 147–175 (2005).
- Langley G , EvansT, HolgateST, JonesA. Replacing animal experiments: choices, chances and challenges. Bioessays29, 918–926 (2007).
- Anonymous. Reduction of the use of animals in the development and control of biological products. Lancet2, 900–902 (1985).
- Lappin G , GarnerC. The utility of microdosing over the past 5 years. Exp. Opin. Drug Metab. Toxicol. 4, 1499–1506 (2008).
Websites
- US FDA, US Department of Health and Human Services. Challenge and Opportunity on the Critical Path to New Medical Products. (2006) Link
- Tracking system for alternative test methods review, validation and approval in the context of EU regulations on chemicals http://tsar.jrc.ec.europa.eu
- European Medicines Agency. Note for guidance on non-clinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals (CPMP/ICH/286/95) (2009) www.ema.europa.eu/pdfs/human/ich/028695en.pdf
- Expert Scientific Group on Phase One Clinical Trials, Final Report, 30 November 2006. The Stationery Office, London, UK, (2006) www.dh.gov.uk/
- The Government Reply to the Report of the House of Lords Select Committee on Animals in Scientific Procedures. Session 2001–2002. Presented to Parliament by the Secretary of State for the Home Department. 4, 7 January 2003 (Cm. 5729) www.archive2.official-documents.co.uk/document/cm57/5729/5729.pdf
- European Partnership for Alternative Approaches to Animal Testing http://ec.europa.eu/enterprise/epaa
- NIH. Countries unite to reduce animal use in product toxicity testing worldwide. News release. 27 April 2009 www.nih.gov/news/health/apr2009/niehs-27.htm